Metraipolis › archive › dc_63b2eb3497cc
The Viloxazine Paradox: A Noradrenergic Agent's Journey From Antidepressant Obscurity to ADHD Precision Therapy — Europe PMC PMID:41947282
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41947282
- DOI
- 10.1002/cns.70839
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T13:00:13.830Z
- SHA-256 of the archived text
4032e96f256d3580473d46b279442d174b11e4d267dc092b05528a3225fd14ca- Stable URL of this page
https://metraipolis.com/documento/dc_63b2eb3497cc
How to cite
The Viloxazine Paradox: A Noradrenergic Agent's Journey From Antidepressant Obscurity to ADHD Precision Therapy — Europe PMC PMID:41947282 — Europe PMC (en), https://europepmc.org/article/MED/41947282 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_63b2eb3497cc (Metraipolis archive dc_63b2eb3497cc, sha256 4032e96f256d3580473d46b279442d174b11e4d267dc092b05528a3225fd14ca)
BibTeX
@misc{dc63b2eb3497cc,
title = {The Viloxazine Paradox: A Noradrenergic Agent's Journey From Antidepressant Obscurity to ADHD Precision Therapy — Europe PMC PMID:41947282},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41947282},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_63b2eb3497cc; sha256 4032e96f256d3580473d46b279442d174b11e4d267dc092b05528a3225fd14ca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41947282. Agents can read the archived copy with the MCP tool read_document.